T
RGEN icon

TCWP’s Repligen RGEN Stock Holding History

TCWP’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-71
Closed -$13K – 1407
2022
Q1 		$13K Buy
+71
New +$13.5K ﹤0.01% 815

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TCWP's RGEN Position: Q2 2022 in Review

TCWP sold out of Repligen (RGEN) in Q2 2022, closing a stake of 71 shares — an estimated $13K sold.

TCWP first reported a position in RGEN in Q1 2022 and held it in 1 quarter. The position peaked at $13K in Q1 2022. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • TCWP reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 71 Repligen shares in Q2 2022, an estimated $13K.
  • TCWP first reported a position in Repligen in Q1 2022 and held it in 1 quarter.
  • TCWP's Repligen position peaked at $13K in Q1 2022.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.